⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic olfactory neuroblastoma

Every month we try and update this database with for metastatic olfactory neuroblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory NeuroblastomaNCT06308575
Metastatic Olfa...
Recurrent Olfac...
Rivoceranib
18 Years - M.D. Anderson Cancer Center
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNCT06176989
Metastatic Chon...
Locally Advance...
Metastatic Sino...
Locally Advance...
Metastatic Larg...
Locally Advance...
Metastatic Olfa...
Locally Advance...
Metastatic Sino...
Locally Advance...
Enasidenib
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNCT06176989
Metastatic Chon...
Locally Advance...
Metastatic Sino...
Locally Advance...
Metastatic Larg...
Locally Advance...
Metastatic Olfa...
Locally Advance...
Metastatic Sino...
Locally Advance...
Enasidenib
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: